Luigi Lorini was awarded the 2024 Martin “Mac” Cheever Excellence in Clinical Trial Design Travel Award for Immunoprevention

This prestigious recognition honors Luigi Lorini’s outstanding contributions to the field of clinical trial design, particularly in the area of immunoprevention.

The award, named after Dr. Martin “Mac” Cheever, a pioneer in cancer immunotherapy, acknowledges Dr. Lorini’s innovative work in designing and advancing clinical trials that focus on preventing cancer through immunological approaches. His research is contributing to the development of novel strategies aimed at harnessing the immune system to prevent cancer in high-risk populations.

This recognition underscores Dr. Lorini’s commitment to excellence in clinical research and his leadership in advancing the field of immunoprevention, which holds the potential to significantly impact cancer prevention and treatment outcomes.

About Luigi Lorini

Dr. Luigi Lorini is a specialist in Medical Oncology and currently serves as an assistant physician at IRCCS Humanitas Research Hospital, within the Head and Neck and Non-Melanoma Skin Cancer Unit. In this role, he is actively engaged in both clinical activities and clinical and preclinical research. Dr. Luigi Lorini is also the young investigator leading several independent clinical trials conducted within GONO (Gruppo Oncologico NordOvest).

In addition to his clinical work, Dr. Luigi Lorini is a member of the EORTC Young Investigator Group, where he collaborates with international researchers to advance the understanding of oncology.

Dr. Luigi Lorini’s expertise in head and neck oncology was further enhanced during a 6-month fellowship program at the Vall d’Hebron Institute of Oncology in 2021. This experience not only deepened his knowledge in head and neck cancer but also provided valuable insights into the design of clinical trials.

An active member of several prominent organizations, including ESMO, EORTC Head and Neck Group, and EORTC Early Career Investigator Head and Neck Group, Dr. Luigi Lorini participates in both national and international research activities. His work spans a wide range of topics, from translational research (such as gene expression and next-generation sequencing) to quality of life assessments and value-based medicine in head and neck cancer care.

Dr. Luigi Lorini is particularly dedicated to rare cancers within the head and neck category, including nasopharyngeal cancer, paranasal sinus cancer, adnexal cancer, and salivary gland cancer. He is actively growing his experience in conducting clinical trials focused on targeted therapies and immunotherapy and currently serves as co-principal investigator (co-PI) on various academic and sponsored clinical trials in these areas.

Luigi Lorini, Medical Oncologist at Humanitas Research Hospital, shared on LinkedIn:

“Great moments at SITC 2024 in the stunning George R. Brown Convention Center in Houston!

It was a honor to receive the Martin ‘Mac’ Cheever Excellence in Clinical Trial Design Travel Award for Immune Prevention.

My heartfelt thanks to the scientific committee and the Cheever family for this significant recognition.

It was fantastic to share this award with Claire Yun Kyoung Ryu Tiger and to learn more about her project!

Immunotherapy in cancer has truly revolutionized treatment, and this is just the beginning! The new data presented at the conference was astonishing, and I am thrilled to continue research in such an exciting field with all the team of the Head and Neck and non melanoma skin cancer unit, leaded by Paolo Bossi, at Humanitas Research Hospital.”

More posts featuring Luigi Lorini on oncodaily.com